Literature DB >> 22325768

Capturing a virus while it catches its breath.

Theodore C Pierson1, Richard J Kuhn.   

Abstract

The four serotypes of dengue virus present a formidable challenge for the development of efficacious human vaccines. Cockburn and colleagues, in this issue of Structure, describe the structural basis of a cross-reactive neutralizing antibody, providing greater insight into immune protection and pathogenesis.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22325768      PMCID： PMC3733089          DOI： 10.1016/j.str.2012.01.014

Source DB:  PubMed          Journal:  Structure        ISSN： 0969-2126            Impact factor:   5.006


  11 in total

1.  Mechanism of dengue virus broad cross-neutralization by a monoclonal antibody.

Authors:  Joseph J B Cockburn; M Erika Navarro Sanchez; Nickolas Fretes; Agathe Urvoas; Isabelle Staropoli; Carlos M Kikuti; Lark L Coffey; Fernando Arenzana Seisdedos; Hugues Bedouelle; Felix A Rey
Journal:  Structure       Date:  2012-01-26       Impact factor: 5.006

Review 2.  A structural perspective of the flavivirus life cycle.

Authors:  Suchetana Mukhopadhyay; Richard J Kuhn; Michael G Rossmann
Journal:  Nat Rev Microbiol       Date:  2005-01       Impact factor: 60.633

3.  Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins.

Authors:  Shee-Mei Lok; Victor Kostyuchenko; Grant E Nybakken; Heather A Holdaway; Anthony J Battisti; Soila Sukupolvi-Petty; Dagmar Sedlak; Daved H Fremont; Paul R Chipman; John T Roehrig; Michael S Diamond; Richard J Kuhn; Michael G Rossmann
Journal:  Nat Struct Mol Biol       Date:  2008-02-10       Impact factor: 15.369

Review 4.  Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms.

Authors:  Alan L Rothman
Journal:  Nat Rev Immunol       Date:  2011-07-15       Impact factor: 53.106

5.  Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever.

Authors:  S C Kliks; A Nisalak; W E Brandt; L Wahl; D S Burke
Journal:  Am J Trop Med Hyg       Date:  1989-04       Impact factor: 2.345

6.  Structural rearrangement of infecting Sindbis virions at the cell surface: mapping of newly accessible epitopes.

Authors:  W J Meyer; R E Johnston
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

7.  Type- and subcomplex-specific neutralizing antibodies against domain III of dengue virus type 2 envelope protein recognize adjacent epitopes.

Authors:  Soila Sukupolvi-Petty; S Kyle Austin; Whitney E Purtha; Theodore Oliphant; Grant E Nybakken; Jacob J Schlesinger; John T Roehrig; Gregory D Gromowski; Alan D Barrett; Daved H Fremont; Michael S Diamond
Journal:  J Virol       Date:  2007-09-19       Impact factor: 5.103

8.  Mapping to completeness and transplantation of a group-specific, discontinuous, neutralizing epitope in the envelope protein of dengue virus.

Authors:  Olesia Lisova; Florence Hardy; Vincent Petit; Hugues Bedouelle
Journal:  J Gen Virol       Date:  2007-09       Impact factor: 3.891

Review 9.  Structural insights into the mechanisms of antibody-mediated neutralization of flavivirus infection: implications for vaccine development.

Authors:  Theodore C Pierson; Daved H Fremont; Richard J Kuhn; Michael S Diamond
Journal:  Cell Host Microbe       Date:  2008-09-11       Impact factor: 21.023

10.  A dynamic landscape for antibody binding modulates antibody-mediated neutralization of West Nile virus.

Authors:  Kimberly A Dowd; Christiane A Jost; Anna P Durbin; Stephen S Whitehead; Theodore C Pierson
Journal:  PLoS Pathog       Date:  2011-06-30       Impact factor: 6.823
View more
  8 in total

1.  Structural changes in dengue virus when exposed to a temperature of 37°C.

Authors:  Guntur Fibriansah; Thiam-Seng Ng; Victor A Kostyuchenko; Jaime Lee; Sumarlin Lee; Jiaqi Wang; Shee-Mei Lok
Journal:  J Virol       Date:  2013-05-01       Impact factor: 5.103

2.  Immunization with Immune Complexes Modulates the Fine Specificity of Antibody Responses to a Flavivirus Antigen.

Authors:  Georgios Tsouchnikas; Juergen Zlatkovic; Johanna Jarmer; Judith Strauß; Oksana Vratskikh; Michael Kundi; Karin Stiasny; Franz X Heinz
Journal:  J Virol       Date:  2015-05-27       Impact factor: 5.103

3.  Insights into the localization and function of myomaker during myoblast fusion.

Authors:  Dilani G Gamage; Eugenia Leikina; Malgorzata E Quinn; Anthony Ratinov; Leonid V Chernomordik; Douglas P Millay
Journal:  J Biol Chem       Date:  2017-08-31       Impact factor: 5.157

4.  Variation of the specificity of the human antibody responses after tick-borne encephalitis virus infection and vaccination.

Authors:  Johanna Jarmer; Jürgen Zlatkovic; Georgios Tsouchnikas; Oksana Vratskikh; Judith Strauß; Judith H Aberle; Vaclav Chmelik; Michael Kundi; Karin Stiasny; Franz X Heinz
Journal:  J Virol       Date:  2014-09-24       Impact factor: 5.103

5.  Dissection of antibody specificities induced by yellow fever vaccination.

Authors:  Oksana Vratskikh; Karin Stiasny; Jürgen Zlatkovic; Georgios Tsouchnikas; Johanna Jarmer; Urs Karrer; Michael Roggendorf; Hedwig Roggendorf; Regina Allwinn; Franz X Heinz
Journal:  PLoS Pathog       Date:  2013-06-20       Impact factor: 6.823

6.  Genotypic Differences in Dengue Virus Neutralization Are Explained by a Single Amino Acid Mutation That Modulates Virus Breathing.

Authors:  Kimberly A Dowd; Christina R DeMaso; Theodore C Pierson
Journal:  MBio       Date:  2015-11-03       Impact factor: 7.867

Review 7.  Adaptive Immunity to Dengue Virus: Slippery Slope or Solid Ground for Rational Vaccine Design?

Authors:  Lucas Wilken; Guus F Rimmelzwaan
Journal:  Pathogens       Date:  2020-06-15

Review 8.  Antibody-Dependent Enhancement: A Challenge for Developing a Safe Dengue Vaccine.

Authors:  Rahul Shukla; Viswanathan Ramasamy; Rajgokul K Shanmugam; Richa Ahuja; Navin Khanna
Journal:  Front Cell Infect Microbiol       Date:  2020-10-22       Impact factor: 5.293
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.